Australia Hits Pfizer With Antitrust Suit Over Lipitor
Australia's competition regulator has sued the domestic unit of Pfizer Inc. over its marketing of the cholesterol-lowering drug Lipitor to pharmacies as the patent protection for the drug was about to...To view the full article, register now.
Already a subscriber? Click here to view full article